One of the golden rules of medical device start-ups is focus. Venture investors, in particular, insist that their portfolio company CEOs keep blinders on in terms of remaining dedicated to a primary product development path and resist the often-tempting possibility to simultaneously try to develop additional products or applications for their technology. That’s why it was somewhat surprising to see that Palo Alto, CA-based Aragon Surgical Inc. , a start-up just emerging from stealth status, launched by veteran device investors Leslie Bottorff of Onset Ventures and David Douglass and John Maroney of Delphi Ventures, had recently completed an acquisition of a second product while its primary product still remains very much in the development stage.
"Diluting a company’s primary focus is always a really big question when a start-up that is still small embarks on...